Pfizer Independent Research Grants
Funding Amount
Not stated
Deadline
Deadline not published
Grant Type
Foundation
Can we apply?
Check your organization against each line. Taken from the listing; confirm with the funder's guidelines.
Eligible organizations
- Qualified researchers are invited to submit investigator-sponsored research (ISR) and General Research proposals
Overview
Pfizer Independent Research Grants support both Investigator Sponsored Research (ISR) and General Research aimed at advancing medical knowledge. Researchers can apply for ISR to conduct studies related to Pfizer assets or General Research for studies unrelated to any Pfizer products. This initiative is open to qualified researchers worldwide, facilitating pre-clinical and clinical studies, health services research, and observational studies to enhance scientific understanding of diseases.
Investigator Sponsored Research (ISR) and General Research
Pfizer supports Investigator Sponsored Research (ISR) projects that advance medical and scientific knowledge about our therapies.
An ISR is a type of grant that supports an independent research study where the investigator or organization is the sponsor of the study and where Pfizer provides financial and/or non-financial support for the development or refinement of specific and defined medical knowledge relating to a Pfizer asset. This global program is open to all researchers who are interested in conducting their own research. This grant type is used as support for pre-clinical and clinical studies (including interventional and non-interventional), that involve a Pfizer asset (e.g., commercial drug, investigational drug, pure compound*).
General Research
Pfizer also supports general research projects focused on the development or refinement of specific and defined medical knowledge unrelated to a Pfizer asset.
This grant type is used to support research that does not include the study of a Pfizer asset, including health services research unrelated to a Pfizer asset, registry development and/or queries unrelated to a Pfizer asset, and outcomes research unrelated to a Pfizer asset. This includes observational studies, such as epidemiology studies and certain outcomes research studies where the primary focus is the scientific understanding of disease as well as other types of independent research on disease states.
Eligibility
Qualified researchers are invited to submit investigator-sponsored research (ISR) and General Research proposals
What The Pfizer Foundation Inc actually gave
Source: IRS Form 990-PF, 2024
- Grants in 2024
- 9,306
- Total given
- $23.24M
Focus Areas & Funding Uses
Fields of Work
- Science research
- Healthcare
Categories
Browse similar grants by category
Related Grants
Open grants from this funder and similar programs
Bronchoscopy Research Grant
Intuitive Foundation
Amount
Up to US $75,000
Deadline
January 4, 2027
Listed date — confirm with the funder
Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
National Institutes of Health
Amount
$1,000,000 total
Deadline
November 9, 2026
Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required)
National Institutes of Health
Amount
$15,000,000 total
Deadline
November 10, 2026
National Center for Construction Safety and Health Research and Translation (U54)
Centers for Disease Control and Prevention - ERA
Amount
$3,000,000 - $5,750,000
Deadline
December 1, 2026
Real-World Data Generation with Elranatamab in Relapsed/Refractory Multiple Myeloma Grant
The Pfizer Foundation Inc
Amount
US $50,000 - US $200,000
Deadline
Deadline not published
Pfizer Clostridioides difficile (C. difficile) Research Collaboration Grant
The Pfizer Foundation Inc
Amount
Up to US $500,000
Deadline
Deadline not published
Ready to apply for Pfizer Independent Research Grants?
Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.
You found Pfizer Independent Research Grants. Now let's win it.